Seroprevalence of dengue infection in the municipalities of Armenia, Calarcá, La Tebaida and Montenegro in Quindío, 2014

Mónica Marcela Jiménez, Jesús Arias, Gabriel Carrasquilla, .

Keywords: Dengue/epidemiology, prevalence, immunoglobulin G, immunoglobulin M, public health, Colombia

Abstract

Introduction: Dengue is a serious public health problem in Colombia; it is prevalent in 90% of the municipalities in Quindío. Studies on its seroprevalence are required to address public health interventions.
Objective: To establish the seroprevalence of dengue infection in neighborhoods with high incidence in the municipalities of Armenia, Calarcá, La Tebaida and Montenegro, Quindío, in 2014.
Materials and methods: We conducted a probabilistic, stratified, two-stage prevalence study. We interviewed 658 residents in the urban area of the selected municipalities. After they signed the informed consent, we took a blood sample to determine dengue IgG and IgM antibodies.
Results: Seroprevalence of IgG in Quindío was 89,4%; in Armenia it was 88,7%, in Calarcá, 81,5%, in Montenegro, 91,8% and in La Tebaida 97,8%. IgM was 14, 2% in Quindío; in Armenia it was 11,5%, in Calarcá, 13,0%, in Montenegro, 13,1% and in La Tebaida, 28,9%.
Conclusions: We found a high prevalence of both IgG and IgM in the four municipalities. We had positive results for IgM in all age groups, which suggests recent infection. We also found simultaneous seropositivity for IgG and IgM (12.9%), which may indicate infection by another serotype or presence of infection in the past three months. A multisectoral approach is necessary for dengue control in Quindío.

Downloads

Download data is not yet available.
  • Mónica Marcela Jiménez Eje de Salud Pública, Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia
  • Jesús Arias Programa de Control de Vectores, Secretaría Departamental de Salud del Quindío, Quindío, Colombia
  • Gabriel Carrasquilla Eje de Salud Pública, Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia
    Investigador asociado

References

World Health Organization. Global strategy for dengue prevention and control 2012-2020. Fecha de consulta: 9 de noviembre de 2015. Disponible en: http://www.who.int/denguecontrol/9789241504034/en/

Murray NE, Quam MB, Wilder-Smith A. Epidemiology of dengue: Past, present and future prospects. Clin Epidemiol. 2013;5:299-309. http://dx.doi.org/10.2147/CLEP.S34440

Organización Mundial de la Salud. Dengue y dengue grave. Nota descriptiva No. 117, mayo de 2015. Fecha de consulta: 9 de noviembre de 2015. Disponible en: http://www.who.int/mediacentre/factsheets/fs117/es/

Mercado M. Informe final dengue, Colombia, 2014. Fecha de consulta: 9 de noviembre de 2015. Disponible en: http://www.ins.gov.co/lineas-de-accion/Subdireccion-Vigilancia/Informe%20de%20Evento%20Epidemiolgico/Dengue%202014.pdf

Villar L, Dayan GH, Arredondo-García JL, Rivera DM, Rivaldo Cunha R, Deseda C, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med. 2015;372:113-23. http://dx.doi.org/10.1056/NEJMoa1411037

Capeding MR, Tran NH, Hadinegoro SR, Ismail H, Chotpitayasunondh T, Chua MN, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomized, observer-masked, placebo-controlled trial. Lancet. 2014;384:1358-65. http://dx.doi.org/10.1016/S0140-6736(14)61060-6

Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;372:113-23. http://dx.doi.org/10.1056/NEJMoa1506223

Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504-7. http://dx.doi.org/10.1038/nature12060

Padilla JC, Rojas DP, Sáenz-Gómez R. Dengue en Colombia: epidemiología de la reemergencia a la hiperendemia. Bogotá: Guías de Impresión Limitada; 2012. p. 80-3.

Instituto Nacional de Salud. Semana epidemiológica número 51 de 2013 (15 al 21 de diciembre de 2013). Fecha de consulta: 9 de noviembre de 2015. Disponible en:

http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2013%20Boletin%20epidemiologico%20Semana%2051.pdf

Instituto Nacional de Salud. Semana epidemiológica número 53 de 2014 (28 de diciembre de 2014 a 3 de enero de 2015). Fecha de consulta: 28 de junio de 2015. Disponible en: http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2014%20Boletin%20epidemiologico%20semana%2053.pdf

Dayan G, Arredondo JL, Carrasquilla G, Deseda CC, Dietze R, Luz K, et al. Prospective cohort study with active surveillance for fever in four dengue-endemic countries in Latin America. Am J Trop Med Hyg. 2015;93:18-23. http://dx.doi.org/10.4269/ajtmh.13-0663http://dx.org.doi:10.4269/ajtmh.13-0663

Pérez-Ortiz NA, Prince WE, Tweeboom JM, Tocci N. Prevalencia del dengue asintomático, por serología, en menores de 15 años del sector Santa Cruz, Puerto Cabello. Revista Electrónica de Portales Médicos.com, 2009. Fecha de consulta: 20 de octubre de 2015. Disponible en: http://www.portalesmedicos.com/publicaciones/articles/1415/1/Prevalencia-del-dengue-asintomatico-por-serologia-enmenores-de-15-anos-.html

Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011;84:200-7. http://dx.doi.org/10.4269/ajtmh.2011.10-0503

Focus Diagnostics. Dengue virus serology testing. 2011. Fecha de consulta: 10 de abril de 2016. Disponible en: http://www.focusdx.com/pdfs/brochures/DXDENI0511_

Dengue_Virus_Serology.pdf

Panbio Diagnostics. Dengue IgM Capture ELISA ,2013. Fecha de consulta: 10 de abril de 2016. Disponible en: http://www.sekisuidiagnostics.com/writable/product_documents/files/ifu_01pe20_dengue_igm_capture_2013.pdf

SPSS Inc. PASW Statistics for Windows. Versión 18.0. Chicago: SPSS Inc.; 2009.

Navarrete J, Acevedo JA, Huerta E, Torres J, Gavaldón DG. Prevalencia de anticuerpos contra dengue y leptospira en la población de Jáltipan, Veracruz. Salud Pública Mex. 2006;48:220-8.

Mohammed H, Tomashek K, Stramer S, Hunsperger E. Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006. Transfusion. 2012;52:1652-6. http://dx.doi.org/10.1111/j.1537-2995.2011.03492.x

Duncombe J, Lau C, Weinstein P, Aaskov J, Rourke M, Grant R, et al. Seroprevalence of dengue in American Samoa, 2010. Emerg Infect Dis. 2013;19:324-6. http://dx.doi.org/10.3201/eid1902.120464

Restrepo BN, Arboleda M, Lopera T. Estudio seroepidemiológico de dengue en la región del Urabá antioqueño, Colombia. Infectio. 2004;8:255-62.

Ali A, Rehman HU, Nisar M, Rafique S, Ali S, Hussain A, et al. Seroepidemiology of dengue fever in Khyber Pakhtunkhawa, Pakistan. Int J Infect Dis. 2013;17:518-23.

http://dx.doi.org/10.1016/j.ijid.2013.01.007

Hoyos A, Pérez A. Prevalencia de infección reciente por dengue en San Mateo, Anzoátegui, Venezuela, 2007- 2008. Rev Cubana Hig Epidemiol. 2012;50:25-8.

How to Cite
1.
Jiménez MM, Arias J, Carrasquilla G. Seroprevalence of dengue infection in the municipalities of Armenia, Calarcá, La Tebaida and Montenegro in Quindío, 2014. biomedica [Internet]. 2017 Jan. 24 [cited 2024 May 11];37(1):34-41. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/3208

Some similar items:

Published
2017-01-24
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code